Key facts
| Price (PPV) | 7,649 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | aflibercept |
| Class | Antineoplastic agents |
| ATC code | L01XX44 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boite d'un flacon de 8 ml de solution |
| Nature | Médicament |
| Hospital price | 7,462 MAD |
| Data collected on | 9/8/2026 |
Indications
ZALTRAP en association avec la chimiothérapie irinotécan/5-fluorouracile/acide folinique(FOLFIRI) est indiqué chez les adultes atteints d’un cancer colorectal métastatique (CCRM) résistant ou ayant progressé après un traitement à base d’oxaliplatine.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Zaltrap 25 mg / ml (SANOFI AVENTIS MAROC) contains the same active substance as Zaltrap 25 mg / ml (Aflibercept) at the same strength, but in a different pack: Boite d'un flacon de 4 ml de solution at 4,024 MAD, i.e. 1,006 MAD per ml against 956.13 MAD for Zaltrap 25 mg / ml. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Zaltrap 25 mg / ml | SANOFI AVENTIS MAROC | Boite d'un flacon de 4 ml de solution | 4,024 MAD | 1,006 / ml |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Zaltrap 25 mg / ml
Zaltrap 25 mg / ml belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Zaltrap 25 mg / ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Zaltrap 25 mg / ml
Answers to common questions from Moroccan patients about this drug.